Patient Access Solutions Expands Locations at Continuum Health Partners

Wednesday, August 18, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

HAUPPAUGE, N.Y., Aug. 18 Patient Access Solutions, Inc. (Pink Sheets: PASO), a leading provider of information technology solutions for the healthcare industry, announced that New York City's preeminent hospital group, Continuum Health Partners, a major healthcare partnership in the State of New York, has increased PASHealth Processing System installations to process its real time HIPAA and self pay receivables transactions. With the addition of these facilities, PAS installation will have increased by 10% and provided the company with additional revenues and an overall contract value of approximately $500,000.

The PAS Systems reside within the various departments of the hospitals, which include Beth Israel Medical Center, St Lukes Hospital, Roosevelt Hospital to name a few, faculty practice offices of the hospitals, and in its outpatient DOCS facilities.

About Continuum Health Partners

Through five of the most respected hospitals in the city, Continuum Health Partners plays a vital and vibrant role in the lives of millions of New Yorkers. The hospitals have nearly 3,100 beds, operate with a budget of over $2 billion, and employ over 15,000 employees, of whom more than 4,000 are nurses.

Since 1997, the mission of Continuum Health Partners has been to provide the city with a health care network that brings together outstanding clinical resources, reinforces strong service traditions, and attracts world-renowned physicians - all while ensuring the highest quality of care for patients.

About Patient Access Solutions Inc.(

Patient Access Solutions Inc. (PASHealth) is a Healthcare Solutions company which has created a formidable array of technology, resources and allies to enable it to become an agent of radical change in what has traditionally been a slowly evolving healthcare environment. For more information about the services and products of Patient Access Solutions, please visit our website at

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the companies, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things, the following: general economic and business conditions; competition; unexpected changes in technologies and technological advances; ability to commercialize and manufacture products; results of experimental studies; research and development activities; changes in, or failure to comply with, governmental regulations; and the ability to obtain adequate financing in the future. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of Patient Access Solutions Inc. Securities and Exchange Commission filings available at

Investor Information 866-280-1156

SOURCE Patient Access Solutions, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store